OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes
In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI
Animal Problems May Stop NIC Construction Grant To city Of Hope
OSCC Groups Send Four Concepts To NCI Board
DCPC BSC Committee Okay Three Concepts
ACS Division Help Fund Some CIS Offices
ELM’s CHOP-DS Aims For 15% Of Patients
Trending Stories
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns









